PAIA
REGN icon

Park Avenue Institutional Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Park Avenue Institutional Advisers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-493
Closed -$172K – 334
2016
Q2 		$172K Buy
493
+3
+0.6% +$1.16K 0.15% 161
2016
Q1 		$177K Sell
490
-15
-3% -$6.18K 0.15% 156
2015
Q4 		$274K Sell
505
-9
-2% -$4.88K 0.24% 102
2015
Q3 		$239K Buy
514
+16
+3% +$8.59K 0.21% 116
2015
Q2 		$254K Buy
+498
New +$243K 0.2% 125

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return